Cardio Diagnostics Holdings, Inc.$3.74 %
Analyst Rating: Hold
Stock Details
CEO
Meeshanthini V. Dogan
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
13
Address
400 N Aberdeen St, Chicago, IL, 60642
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Top Competitors
Income Statement
Financials
Selected Year
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for Cardio Diagnostics Holdings, Inc. $3.74
$0
Min Forecast(+0% )
$249.61
Avg Forecast( +0% )
$325
Max Forecast(+0%)
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results